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Background: The effectiveness of pyrethroid-treated bednets for malaria control in sub-Saharan Africa is under
threat because of high levels of resistance to pyrethroid insecticides in the vectors. Here we assess the durability of
polyethylene nets with a novel combination of permethrin, a pyrethroid, with pyriproxyfen, an insect juvenile mimic
(PPF-LLIN), in comparison with a typical permethrin-treated long-lasting insecticidal net (LLIN).
Methods: This is a cluster randomised controlled trial of net durability in Burkina Faso, with clustering at the level
of the compound and includes entomological outcome measurements. Half the compounds in each village will be
randomly allocated PPF-LLIN and half the LLIN. All sleeping places in a compound will be provided with one type
of net. We will distribute the nets at the start of the first transmission season and follow net use at the start and
end of each transmission season for 3 years. In one village, bio-efficacy and chemical content will be recorded
immediately after net distribution and then at 6, 12, 18, 24, 30 and 36 months. In the other village net survivorship
and fabric integrity will be recorded immediately after distribution, and then at 6, 12, 18, 24, 30 and 36 months.
Routine measurements of indoor temperature and relative humidity will be made in both villages during the study.
Residents will be followed for possible side effects of the PPF-LLIN by surveillance of known asthmatic subjects
during the first month post-distribution and pregnancy outcomes will be monitored from antenatal clinic records.
Discussion: The protocol is novel on two accounts. Firstly, it is the first to describe the procedure for measuring
net durability following recent World Health Organisation (WHO) guidelines. Meeting the minimum requirements
set in the guidelines is essential before a new type of net can be recommended by WHO’s Pesticide Evaluation
Scheme (WHOPES). Secondly, it describes methods to monitor the persistence of an active ingredient that reduces
vector fertility and fecundity. If the PPF-LLIN is both effective and persistent it will provide an alternative vector
control strategy where pyrethroid-resistant vectors are present.
Trial registration: ISRCTN30634670 assigned 13 August 2014.
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The massive scale-up of long-lasting insecticidal nets
(LLINs) has contributed to a decline in malaria in many
parts of sub-Saharan Africa (SSA) over the past decade
[1,2]. Pyrethroids remain, until now, the only class of in-
secticide used for treating nets since they are highly in-
secticidal and safe to use [3]. However, the rapid
increase in resistance to pyrethroid insecticides in mos-
quitoes may jeopardise future malaria vector control [4].
Polyethylene nets, containing a novel combination of
permethrin, a pyrethroid, and pyriproxyfen (PPF-LLIN),
an insect juvenile hormone mimic [5-8], may enhance
malaria control, as well as reducing the spread of
pyrethroid-resistant mosquitoes.
A two-armed cluster-randomised controlled trial
(AvecNet) [9] is being conducted near Banfora, Burkina
Faso, to assess whether PPF-LLINs (Olyset Duo nets
containing 2% permethrin, 1% pyriproxyfen w/w) pro-
vide better protection against clinical malaria in children
than 2% permethrin-treated LLINs (Olyset Nets) in an
area with high levels of pyrethroid resistance in the main
vector, Anopheles gambiae s.s. [10]. At the start of the
study, 33% mortality was obtained after exposure to a
discriminating dose of permethrin (0.75% papers for
1 hour exposure) and the time to kill 50% after exposure
to the discriminating dose was 91 minutes. In the
current study we propose to measure the durability of
both PPF-LLINs (Olyset Duo) and LLINs (Olyset), used
as a control, under operational conditions for 3 years to
complement the efficacy results of the main trial. Since
all villages in the main trial will have PPF-LLINs by the
end of the 2-year trial, this durability study will take
place in villages outside the main trial and adverse
events (AE) will be monitored as for the main trial.
Recently it has become apparent that while the Olyset
brand of LLINs has excellent tensile strength and insecti-
cidal properties that last for many years, the netting is
prone to develop elongated holes due to the weave unrav-
elling once a small hole develops. Thus, large-scale sur-
veys, supported by the President’s Malaria Initiative, of
national LLIN distributions in several African countries
found that after 2 years of domestic use, Olyset nets some-
times scored badly on fabric integrity in comparison to
many other brands [11]. The manufacturer has acted on
these findings and changed the knitting pattern of the
Olyset Net, which inhibits the development of elongated
holes, so that since late 2013 all Olyset Nets manufactured
have this new knitting pattern (J Lucas, personal commu-
nication). In our durability trial we will use new knitting
pattern nets for both the PPF-LLIN and LLIN. Durability
of PPF-LLINs and LLINs will be assessed using 3 criteria:
(1) net survivorship, (2) fabric integrity and (3) insecticidal
activity (bio-efficacy). This protocol follows the recom-
mendations made by WHO in 2013 entitled ‘Guidelinesfor monitoring the durability of long-lasting insecticidal
mosquito nets under operational conditions’ [12], WHO’s
2013 ‘Guidelines for laboratory and field testing of long
lasting insecticidal nets’ [13] and WHO’s Vector Control
Technical Expert Group’s guidelines on ‘Estimating
functional survival of long-lasting insecticidal nets from
field data’ [14].
This protocol is the first we know of that adheres to
these guidelines. It therefore serves as an exemplar for
other studies wishing to adopt these criteria.
Study objectives
Primary objective
To determine whether the bio-efficacy of PPF-LLINs is
superior to that of LLINs for the first 36 months after
net distribution.
Secondary objective
To determine the physical integrity of LLIN and PPF-
LLINs for the first 36 months after net distribution.
Tertiary objectives
1. To determine the survivorship of LLIN and PPF-
LLINs for the first 36 months after net distribution.
2. To measure the content of permethrin in LLINs and
permethrin and PPF in PPF-LLIN netting for the
first 36 months after net distribution.
3. To document AE that may be associated with PPF-
LLIN use.
Methods/Design
Study area
The study will be carried out in two villages in the Cas-
cades Region of Burkina Faso. In Dalamba (village A) sam-
ples will be cut from nets and the nets will be replaced
(Primary objective and Tertiary Objective 2) and Sanako
(village B), where nets will be left intact (Secondary object-
ive and Tertiary Objectives 1 and 3). AE will be followed
in both villages. The separation of activities in two villages
is designed for operational reasons to simplify data collec-
tion and analysis since in village A nets will be replaced
through the course of the trial, whilst in village B nets will
be delivered and hung only at the start of the trial. This ar-
rangement is also less likely to create dissatisfaction
amongst those who will not get replacement nets. The
study villages have a total population of approximately
2,000 and are situated close to the south-east of Banfora
(10° 56′ 00″ N, 004° 46′ 00″ W) in an area of open
Sudanian savannah. These villages are located near those
enrolled in the main AvecNet Trial, but are outside the
main study area. Most people in the main trial and in this
study live in houses made with mud or cement walls and
thatched or metal roofs. The climate is tropical with most
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seasonal malaria transmission with most malarial episodes
experienced during or immediately following the major
rains. The study’s field station is based at Banfora town,
which is the main town in the district. This is an area of
cotton-growing since 1968 with An. gambiae S forms pre-
dominating over M forms [15].
Net owner enrolment
As is customary in Burkina Faso, sensitisation will start
by discussions with community elders and then repre-
sentatives of the villages in order to explain the nature
of the study and what will be required during the study
(information sheet, Additional file 1). The key attendees
names and roles will be documented for each village.
We will explain to individual net owners the purpose
of the study and will provide them with an information
sheet (Additional file 1). Witnessed written consent
(Additional file 1) will be obtained from each participant,
before net donation and exchange of their previous net.
We will also seek written consent from net owners be-
fore taking netting samples. During these procedures it
will be made clear that subjects and households will be
able to leave the study at any time without giving a rea-
son but their original net will not be returned. Given the
nature of the study we will also encourage participants
to keep the nets they are given and not to exchange
them. We envisage that most study subjects will be en-
rolled at the start of the study for 36 months. Occasion-
ally, due to movement of residents into the villages,
some subjects join during the study.
Randomisation and blinding
Both types of net will be randomly allocated to com-
pounds, with allocation stratified by compound size in
both villages. In village A 6 different compounds will be
sampled in each study arm at 7 sequential time points:
thus, 84 compounds (42 for each study arm) will be se-
lected randomly, without replacement, at the start of the
study. The remaining compounds in the village will be
randomly assigned equally to the intervention or control
and will act as reserve compounds in case of withdrawal
of those randomised. At each sampling time point 4 nets
will be randomly selected from each of the pre-selected
compounds: that is within 1 to 2 weeks of hanging and
then 6, 12, 18, 24, 30 and 36 months later. As holes will
be cut in the selected nets to provide netting samples for
laboratory testing, the nets will be taken from the recipi-
ent and replaced with a new one of the same type: that
is LLINs will be replaced with LLINs and PPF-LLINs re-
placed with PPF-LLINs. A total of 649 nets will be dis-
tributed in Dalamba (village A) and 541 in Sanako
(village B). In cluster-randomised controlled trials it is
particularly important to minimise imbalance for factorslikely to be correlated with the outcome; bio-efficacy will
probably be affected by net washing and possibly by the
ambient temperature and humidity, this will be cor-
rected for in the analysis. Observer bias will be reduced
where feasible. Both types of nets will be of a similar
shape and colour and will be blinded before distribution,
see below. Thus, end-users, field workers conducting the
physical integrity/survivorship surveys and technicians
conducting the bio-efficacy, fabric integrity and insecti-
cide content tests will be blinded to the type of net. A
standard questionnaire will be used to collect data from
the net user at each follow-up. The processes of the in-
terventions, both for PPF-LLINS and LLINs, will be
closely monitored not only for quality but also to docu-
ment any bias between the clusters and villages.
Interventions
The LLINs and PPF-LLINs distributed will be manufac-
tured by Sumitomo Chemical Company (Japan) and are
the same as those being used in the main AvecNet Trial,
model ‘Extra Family’ rectangular (180 cm wide × 190 cm
long × 150 cm high), except that these will have been
manufactured using the improved (new) knitting pattern.
The LLINs are WHO recommended and meet WHO
specifications (http://www.who.int/whopes/Long_lasting_
insecticidal_nets_Aug09.pdf ) with 2% w/w permethrin
incorporated into polyethylene fibres. The PPF-LLINs
contain 2% w/w permethrin and 1% w/w pyriproxyfen
incorporated into polyethylene fibres. Olyset Duo was
submitted to WHOPES in August 2012 and has re-
cently completed Phase I testing. These nets will be dis-
tributed at the beginning of the main transmission
season, at no cost to the recipients. Government Roll
Back Malaria information, education and communica-
tion procedures will be followed to encourage correct
net use and maintenance. The storage and distribution
of the LLIN and PPF-LLIN will follow the same proce-
dures as detailed in the main AvecNet Trial Protocol
(submitted June 2014). In addition, as this trial will be
blinded for the recipients and survey field assistants
and laboratory staff, nets will be given sequential unique
identity (ID) numbers in the top right hand corner of the
label and all mention of ‘Olyset’ and ‘Olyset Duo’ removed
before the start of net distribution. This will include blind-
ing or replacing bags in which the nets are supplied from
the manufacturers. The ID and net type will be noted on
specific forms, which will kept in a sealed envelope and
locked under the supervision of the Principal Investigator
(PI) until the datasets are finalised and locked.
The date the nets are given to the householder will be
written under the unique identifier at the time of dona-
tion so that all nets will be numbered with a unique ID
number and the date of issue. The recipient’s name, net
number, date of donation and identity of the compound
Figure 1 Position of samples taken from each panel of the
bednets [12].
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corded on the clinical report form (CRF) at the time of
delivery. The household identification, name of head of
household, and global positioning system (GPS) coordi-
nates will be recorded at the baseline demographic sur-
vey. Both types of net will be the same design and
colour so that study participants will be blinded to the
net allocation. However, each net ID will be coded and
the location and recipient recorded as indicated above
and this information will be collected at each survey to
keep track of the identity of each net.
Study procedures and evaluations
The study villages will be enumerated following normal
demographic surveillance procedures and compounds
mapped before being randomised to net type. It is
intended that LLIN distribution will be completed by
July/August 2014. Nets selected for monitoring will be
identified by their unique ID, date of donation and lo-
cated by the village, household number, name of the
head of household and user name. Net users who have
moved, and taken their nets with them, or withdrawn
consent will be recorded on the survey form and on the
master list and they will be replaced by another net user
from the same compound. If an entire compound re-
fuses to participate another compound will be randomly
selected from those remaining.
Surveys will be conducted in village B at 0, 6, 12, 18,
24, 30 and 36 months post-distribution for all endpoints.
A standard questionnaire will be used to collect data at
each follow-up from the net user, or parent/carer in the
case of children. The following information will be re-
corded: whether the net is hung over the sleeping place
at the time of visit, whether it is in storage, being
washed, given away or discarded, the method of hanging,
whether it can be tucked securely under the mattress all
around, and the fabric integrity and the condition of the
net. In village B all available nets will be surveyed each
time point, in village A only the compounds randomised
for sampling at each time point will be surveyed.
Net selection and sampling
Village A will be used to sample nets for bio-efficacy
assay and the measurement of insecticide content, as de-
tailed in ‘randomisation and blinding’ above. Samples
will be cut from the nets while they are hanging in the
villages. The bio-efficacy assay requires 3 samples of
25 cm2 from each net (Positions 2, 3 and 4; see Figure 1).
Following the WHO guidelines [10,11] the measurement
of insecticide content will made on 5 pieces of 30 cm2
from each net immediately after distribution (positions 1
to 5 in Figure 1) and 4 pieces of 30 cm2 from each net 6,
12, 18, 24, 30 and 36 months later (positions 2, 3, 4 and
5). The bio-efficacy samples will be wrapped individuallyin aluminium foil but all the samples taken to measure
insecticide content from a single net will be wrapped to-
gether. After wrapping in foil the samples will be la-
belled with the type of assay, the date of sampling and
the net ID plus the position sampled (for example, 092–
3 is net ID 92, cut from position 3). Samples will be
stored at +4°C, and left for 24 hours at room
temperature until assayed.
Village B will be used to measure net survivorship and
fabric integrity immediately after net distribution and
then 6, 12, 18, 24, 30 and 36 months later.
Bio-efficacy (Dalamba, village A)
Bio-efficacy tests will use the net samples from village A
and will be conducted in laboratories. The knockdown,
mortality and blood feeding tests will be conducted in
Burkina Faso while those for egg production and pro-
duction of viable larvae will be conducted at the
Liverpool School of Tropical Medicine, UK.
Mosquitoes
The knockdown and mortality tests will use a standard
laboratory colony of permethrin-susceptible An. gambiae
s.s. (Kisumu strain) aged 2 to 5 days old without blood
feeding. The tests for egg and larvae production will use
standardised laboratory colonies of permethrin-resistant
An. gambiae s.s. (Tiassale strain) with blood feeding.
This resistant colony will be submitted to regular quality
testing, both phenotypic and genotypic, during the study
to control for any changes in resistance levels.
Test procedures
a) Measuring knockdown and mortality
Knockdown and mortality will be measured using
WHO cone bioassays [12]. Since 3 net samples will be
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tested for each arm at each time point and a total of 1,008
samples overall. Two standard WHO cones are fixed with a
plastic manifold onto each of the three netting pieces, one
at a time. Five permethrin-susceptible, non-blood-fed, 3- to
5-day-old female An. gambiae s.s. will be exposed for
3 minutes in each cone and then held for 24 hours with
access to 6% sugar solution. Knockdown will be mea-
sured 60 minutes after exposure, and mortality measured
after 24 hours. A negative control, from an untreated net,
will be included in each round of cone bioassay testing.
Bioassays will be carried out at 27 ± 2°C and 80 ± 10%
relative humidity. Bioassay results for the netting pieces
from each sampled net will be pooled to determine if the
net meets the WHO efficacy requirement: that is ≥ 80%
mortality. If the net fails these criteria, a tunnel test will be
conducted on one of the four net samples that caused
mortality closest to the average mortality in the cone
bioassay [12].
b) Measuring egg production and viable offspring
Here the assay is designed to mimic what is likely to hap-
pen in nature by measuring egg and larval production in
blood-fed, permethrin-resistant mosquitoes after exposure
to the netting samples. Batches of 10, 3-day-old unfed mos-
quitoes will be exposed to LLIN, PPF-LLIN or untreated
netting samples for 3 minutes using WHO cone bioassays
[10]. At each net sampling time point, the same three
panels will be tested for the six nets sampled from the field
for each of the two types of netting. In addition a control
untreated netting will be tested in duplicate. So for each
of the 7 time points, 380 mosquitoes are tested (10
mosquitoes/test × 3 net panels/net × 6 nets/net type ×
2 net types, plus 2 control nettings).
After exposure to the netting samples the female mosqui-
toes will be transferred to cages containing an equal num-
ber of newly emerged male mosquitoes and provided with
6% glucose solution ad libitum. Then, 24 hours after expos-
ure to the netting samples the female mosquitoes will be
fed on animal blood using membrane feeders for 25 minutes
and any unfed mosquitoes recorded and discarded. After
feeding, gravid mosquitoes will be individually placed into
15-cm3 cages, provided with an oviposition substrate of tap
water in a 100 ml glass cup and left overnight to lay eggs.
The following morning the number of eggs laid by individ-
ual females will be recorded. Eggs laid by each female will
be transferred into individually-labelled plastic cup and the
number of eggs hatching every 24 hours will be monitored
for 3 days.
Insecticide content (Dalamba, village A)
Insecticide content is the amount of active ingredient
per gram of netting as determined by chemical assay.The net pieces of 30 cm2, cut from intact nets will be
used to determine insecticide content. A sample from
position 1 of the net will be included in baseline assays,
but not in subsequent assays. Net samples will be
weighed to estimate their density (mass of net per unit
area) and then the samples from the same net will be
combined for chemical analysis. The results will estimate
the total active ingredient content of permethrin on the
LLIN and pyriproxyfen and permethrin on PPF-LLIN.
The Liverpool School of Tropical Medicine will conduct
the chemical assay using analytical methods (Collaborative
International Pesticides Analytical Council) recommended
by WHO for quality control will be used to determine the
total content of the active ingredient (unpublished
method).
Net survivorship (Sanako, village B)
To measure survivorship, all nets distributed to study
subjects will be recorded. At each time point study nets
will be visited and the physical presence of the net re-
corded. Those hanging over a bed will be considered as
being in use. If the net is still present in the household,
the investigator will record whether the net is being used
for its intended purpose. Nets that have never been used
will be recorded but excluded from the main analysis. If
the net is no longer in the house, the investigator will
determine how it was lost. This will be categorised as
follows: loss by giving away the net to others to use ei-
ther voluntarily (given to friends and relatives or sold)
or involuntarily (stolen), and loss due to destruction, dis-
carding or using it for alternative purposes because it is
perceived as ‘useless’ [14]. These data will allow an esti-
mation of the ‘hanging rate’ of bednets and allow us to
better understand the reasons for net attrition.
Fabric integrity (Sanako, village B)
Fabric integrity will be assessed from the questionnaire
by counting the number of holes, including tears in the
netting and split seams, by their location on the net and
their size. Holes will be classified using the proportion-
ate Hole Index (pHI) [14] into the following categories:
good (pHI range 0 to 64), acceptable (pHI 65 to 642)
and torn (≥643).
Environmental measurements
The indoor temperature and relative humidity will be re-
corded continuously in 6 randomly-selected houses in
each village from 0 to 36 months after net distribution
to establish the environmental conditions present in the
study houses. Data loggers (Lascar EL-USB-2-LCD Data
Logger 80°C 100%RH) will be positioned at 1 metre
above the floor on the wall nearest the foot end of the
bed. Measurements will be made once an hour and the
data will be downloaded every month.
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We consider that any AE arising from either net are
highly unlikely. Nonetheless to document the safety of
the use of these tools in a community setting, as in the
main AvecNet Trial [9], residents will be followed for
possible side effects of the PPF-LLIN by surveillance of
known asthmatic subjects during the first month post-
distribution and pregnancy outcomes will be monitored
from antenatal clinic records.
Safety considerations
There are no apparent risks to the safety of individuals
or communities in this study. Permethrin-treated long-
lasting nets have been fully evaluated by the WHO Pesti-
cide Evaluation Scheme and approved for vector control
(www.who.int/whopes/en/), and the products will be
used in compliance with their recommended use and
guidelines. The WHO hazard classification of permeth-
rin is Class II, moderately hazardous [16]. The WHO
hazard classification for pyriproxyfen is: U, unlikely to
present acute hazard in normal use [16]. Pyriproxyfen is
applied to drinking water sources for vector control be-
cause of its high insecticidal activity and low mammalian
toxicity [3]. A recent WHO document [17] illustrates the
low toxicity of pyriproxyfen for mammals: ‘pyriproxyfen
was not toxic when administered dermally to rats for
21 days at doses of up to 1,000 mg/kg of body weight per
day. Inhalation of pyriproxyfen for 4 hours per day for
28 days caused only minor effects in rats (initial salivation,
sporadically reduced body weight gain, slightly increased
serum lactate dehydrogenase activity) at 10,000 mg/m3’.
Handling of drop-outs/withdrawals
If an individual wants to terminate his/her participation,
no further follow-up will be performed. Net owners who
have withdrawn consent, or are no longer in the study
for whatever reason, will be replaced by other net
owners resident in the same compound when possible.
If a village opts out of the study during the first year, re-
placement by a neighbouring village will be considered.
Study endpoints
Primary: bio-efficacy
Bio-efficacy is measured as percentage adult female mor-
tality 24 hours after exposure to netting and as the per-
centage of viable offspring (first or second stage larvae)
relative to the control group.
Secondary: fabric integrity
Fabric integrity will be as defined earlier using the pHI
[14] grouped into the following categories: good (pHI
range 0 to 64), acceptable (pHI 65 to 642) and torn
(≥643).Tertiary: net survival
Comparisons will be made between functional LLIN sur-
vival [14] with both types of nets.Tertiary: chemical analysis
The content of permethrin and pyriproxyfen in
netting samples will be expressed in both g/kg and
mg/m2.Sample size rationale
Primary outcome
Bio-efficacy - measured in Dalamba, village A WHO
expects that LLIN netting will kill at least 80% of mos-
quitoes that land on it. In this trial, however, the effects
of the PPF-LLIN netting are not just on killing mosqui-
toes, but also causing sterility and reducing the number
of offspring produced by female mosquitoes. A 50% re-
duction in killing when exposed to LLINs nets is likely
to impact malaria vector control, as is a 50% decrease in
the proportion of gravid females laying eggs after expos-
ure to PPF-LLINs. In order to detect 50% reduction in
killing from 80% to 40% and a coefficient of variation
between clusters of 0.25, a conservative estimation, one
requires 6 compounds with 4 nets, each with 3 netting
samples/net/time, in each cluster to demonstrate a sta-
tistically significant impact at the 5% level and with 80%
power. These calculations are based on the formula of
Hayes and Bennett for clustered data [18]. For the 7
time points, one needs to recruit forty two compounds
to each study arm.Secondary outcome
Fabric integrity - measured in Sanako, village B Since
LLIN and PPF-LLIN are manufactured with the same
fibre, the same weave and are manufactured by the same
company we would not expect to find a difference in
fabric integrity between them. However, a control
programme manager might consider replacing all the
nets in an area if > 25% were of poor condition. To esti-
mate 25% nets in poor condition with a precision of
±10%, with a design effect of 1.0 because of cluster sam-
pling, at the 5% level of significance, assuming there are
either 500 LLINs or PPF-LLINs, would require 64 nets
in each arm at the last sampling time. To allow for a loss
of 10% of nets per year and for operational uniformity it
is simplest to maintain the study framework of 100 nets
in each group to allow for loss to follow-up if net users
move away or stop using their nets; in which case, we
would sample four nets in twenty-five compounds in
each study arm. In addition, direct comparisons will be
made between both nets.
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Net survival - measured in Sanako, village B For sim-
plicity and to maximise precision of this measure, all
nets will be sampled at 6-monthly time intervals: that is
374 of LLIN and 167 of PPF-LLIN. Direct comparisons
of functional LLIN survival will be made between both
net types using Kaplan-Meir analysis.Chemical analysis measured in Dalamba, village A
A 75% decline in the total content of either permethrin
or PPF would cause concern since this is likely to impact
the operational effectiveness of PPF-LLIN. The total
concentration of PPF and permethrin in the fibres will
be compared to the insecticidal activity overtime to
examine their relationship. The manufacturers certify
that the PPF-LLIN contain 2.0 g permethrin/g fibre, with
range 1.5 g to 2.5 g and 1.0 g PPF g/g fibre, with range
0.75 to 1.25 g. In order to detect a 75% reduction in
insecticide from 2.0 g to 0.5 g with a coefficient of
variation of 0.25 (considered appropriate for factory-
produced products where variation between nets is
considered small) at the 5% level of significance and
80% power we will require 4 compounds in each study
arm with 5 nets tested in each compound (n = 20 nets
in each group). Since nets will be damaged during
sampling they will be replaced with a new intact net.
For this reason it is important that the date at which
the net was put in place is recorded directly on each net.Data handling and record keeping
Entomological and environmental data will be recorded
by field assistants and the clinical data by study nurses
on standardised data forms. Each net will have a unique
ID number and study subjects participating in the cross-
sectional surveys will have their demographic surveil-
lance number. All data recorded on individuals will be
made by recording their demographic surveillance num-
ber, the village of residence and initials of the study sub-
ject; the initials will not be entered into the dataset to
maintain anonymity.
Data forms will be double-entered, firstly by field staff
and then by data entry staff, and the entries combined
and errors corrected to produce a single dataset. This
will be submitted to consistency checking by generic
and study specific algorithms designed to identify
sources of error. When inconsistencies occur, these will
be checked against the original forms and subsequently
amended in the dataset. Errors will be corrected when
possible, with checking in the field when necessary and
possible, to produce final datasets.
All forms with subject names and/or clinical data will
be kept in a cabinet and locked when not in use; the key
will be kept by the study coordinator or delegate. Theelectronic datasets will be password protected. Hard
copies of the data will be stored for 10 years. The clinical
data will be kept separately from that containing per-
sonal information. All forms and datasets, apart from
those for enumeration, will identify subjects by their
demographic surveillance number and initials and names
will not be collected and initials will not be entered.
After the collection and verification, data will be moved
to data management unit in Banfora for data entry. The
datasets will be password protected and only accessed by
authorised study staff and the study data manager until
after publication. Data will be stored for at least 10 years.
The PI will ensure that appropriate medical and re-
search records for this study are maintained in compli-
ance with Good Clinical Practice (GCP) and regulatory
and institutional requirements. Authorised representatives
of the sponsor, the ethics committee(s) or regulatory bod-
ies may inspect all documents and records required to be
maintained by the investigator. The PI, or designee, will
ensure the access to facilities and the records.Data analytical plan
Bio-efficacy
Mortality If the mortality in the control is between 5%
and 20%, the data will be adjusted with Abbott’s formula
shown below:
Adjusted % mortality = (% alive in control - % alive in
treatment) × % alive in control
If the mortality in the control is > 20%, all the tests will
be discarded for that day.
General linear modelling will be used to assess the
activity of the different insecticide treatments over
time, adjusting for compound. Kaplan-Meier survival
analysis will be used to compare treatments over time.Reduction in offspring
If less than 20% of gravid females in the control group
fail to lay eggs the experiment will be repeated.
General linear modelling will be used to assess the ac-
tivity of the different insecticide treatments over time,
adjusting for compound. Kaplan-Meier survival analysis
will be used to compare treatments over time.Fabric integrity
Three indicators will be calculated at each survey time:
1) the proportion of torn nets, 2) the proportion of nets
with holes and 3) a hole index.
Proportion of nets in poor condition (with 95% confi-
dence interval):
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nets are not long enough to be tucked under the
mattress, or are torn or badly damaged, or have more
than 5 holes (finger-width, approximate diameter 2 cm)
Denominator: total number of each net type found and
assessed in surveyed households
Proportion of nets with any holes (with 95% confi-
dence interval):
Numerator: fabric integrity will be defined using the
pHI [14] grouped into the following categories: good
(pHI range 0 to 64), acceptable (pHI 65 to 642) and
torn (pHI ≥ 643)
Denominator: total number of each net type found and
assessed in surveyed households
The hole index would be calculated as:
Hole index = (0.5 to 1.9 cm2 × number of size-1 holes) +
(2.0 to 9.9 cm2 × number of size-2 holes) + (10.0 to
24.9 cm2 × number of size-3 holes) + (≥25.0 cm2 × num-
ber. of size-4 holes)
The holes will be weighted according to the average
area of each hole category. For the hole size categories
described above, the weights would be 1, 23, 196 and
578, which corresponds with the areas estimated on the
assumption that the hole sizes in each category are equal
to the mid-points.
For each net type, the mean and standard deviation as
well as the median and inter-quartile range of the hole
index will be determined. Comparisons between treat-
ments at different periods will be made using generalised
linear models, adjusting for compound.Net survival
The analysis will include data on all nets recorded at
each time interval. The number of nets in the sample,
the proportion of the indicator and 95% confidence
interval will be reported. The following indicators will be
used and disaggregated by survey time (for example,
0 weeks, 6, 12, 18, 24, 30 or 36 months):
Survivorship:
Numerator: total number of nets in ‘good’ condition
(pHI 0 to 64) plus ‘acceptable’ condition (pHI 65 to
642) hung over a bed × 100
Denominator: total number of each net type distributed
to surveyed households, excluding a portion (those that
may be still in use by others) of the number lost by
attrition
Attrition rate-1 for nets that have been destroyed or
disposed of:Numerator: total number of each net product
documented as lost due to wear and tear
(‘torn’, pHI > 642) in surveyed households × 100
Denominator: total number of each LLIN type
distributed to surveyed households, excluding the
number lost by attrition
Attrition rate-2 for nets not available for sleeping
under:
Numerator: total number of each net product reported
as lost for reasons other than ‘torn’ (given away, stolen,
sold or used in another location) in surveyed
households × 100
Denominator: total number of each net product
distributed to surveyed households
Attrition rate-3 for nets used for other purposes:
Numerator: total number of each net product reported
as being used for another purpose in surveyed
households × 100
Denominator: total number of each net product
distributed to surveyed households
For each net product, the survivorship rate plus
attrition rate-1, attrition rate-2 and attrition rate-3 will
add up to 100%.
Kaplan-Meier survival analysis will be used to assess
survivorship of nets with the log rank test being used
to ascertain whether there are statistically significant
differences between the two types of netting.
Chemical analysis
The mean concentration and 95% confidence intervals
of permethrin and pyriproxyfen will be measured on
netting at time 0, and after 6, 12, 18, 24, 30 and
36 months.
Environmental measurements
The maximum and minimum indoor temperature and
relative humidity will be determined monthly for both
villages during the study.
Ethical approval
This study is conducted in accordance with the princi-
ples set forth in the ICH Harmonised Tripartite Guide-
line for GCP and the Declaration of Helsinki in its
current version, whichever affords the greater protection
to the participants. This protocol has been approved by
the Ethics Committee for Research in Health, Ministry
of Scientific Research and Innovation, Burkina Faso
(2014-0-0250) and the School of Biological Sciences
ethics committee, Durham University, UK (SBBS/EC/
PV120914).
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Insecticide-treated bednets are a highly effective vector
control tool [19] but their future success is threatened
by the spread of vectors resistant to pyrethroids [4],
which is presently the only class of insecticide used for
treating bednets. Finding alternative strategies to deal
with the problem of insecticide resistance is a priority
for malaria control and strategies leading to elimination
[20]. Since bednets are effective methods of malaria con-
trol and have been used in their millions across SSA, in-
secticide resistance strategies that focus on bednets have
much to recommend them. Here, we test a new net with
a combination of two active ingredients: permethrin, a
pyrethroid, and pyriproxyfen, a juvenile hormone mimic.
Unlike permethrin, the principal mode of action of pyri-
proxyfen is not to kill mosquitoes, but to reduce their fe-
cundity and fertility following a blood meal [6-8].
Ideally, the new combination must be effective for sev-
eral years in order for it to be a useful public health
intervention and to be recommended by WHOPES. In
this trial we follow the recent recommendations made
by WHOPES for assessing the durability of LLINs [12]
and describe them in a protocol for others to adapt. Net
durability will be assessed using a number of criteria.
Specifically, this includes measuring the bio-efficacy and
chemical content in the nets over time in one village, as
well as the net survivorship and fabric integrity in a sep-
arate nearby village. Although we think it unlikely that
there will be any adverse reactions to the new net con-
taining pyriproxyfen we will record any AE in asthmatics
and pregnant women.
The chemical measurement with time will give an in-
dication of the longevity of the pyrethroid and pyriprox-
yfen in polyethylene netting in a typical rural village
setting and the bioefficacy measures will give an indica-
tion of the activity of these compounds on the surface of
the netting. The study is being run for 3 years as this is
the current estimation of time between large-scale dona-
tion campaigns adopted by WHO and donor agencies,
which balances expected net survival time and cost.
The nets used in the current study are of polyethylene,
which was selected as the chemicals are incorporated
into the fibres, which increases the duration for which
pyrethroid is available and effective on the surface of the
fibres. However, the duration of the pyriproxyfen is not
known. The bio-efficacy measurements on pyriproxyfen
include measurement of survival and fecundity of pyr-
ethroid resistant An. gambiae s.s. after exposure to both
the pyrethroid only net and that with pyriproxyfen over
time. The effect of washing, in a village setting, on in-
secticide durability will also be examined.
If we can demonstrate in our main trial that large-
scale use of the PPF-LLIN net reduces clinical malaria in
children and in this trial that the nets are durable,remaining effective for a number of years in an area with
pyrethroid-resistant vectors, then the results of these tri-
als will be of interest to malaria control programmes in
Burkina Faso and other parts of SSA.
Trial status
Recruiting.
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